World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
12096
World Ranking
12569
National Ranking
231

Genevieve Laureys publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Genevieve Laureys sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 287 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Genevieve Laureys D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Genevieve Laureys sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 59 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Genevieve Laureys is affiliated with Ghent University Hospital in Belgium and has contributed extensively to research in medicine, with a particular focus on biochemistry, genetics, and molecular biology. Their publications cover a wide range of topics, primarily within neurology, cancer research, molecular biology, oncology, and pediatrics, perinatology, and child health.

Their research emphasizes the study and treatment of neuroblastoma, cancer genomics and diagnostics, and cancer therapeutics and mechanisms. Additional areas of work include lung cancer research, cancer-related hypoxia and metabolism, renal cancers, and the quality of life for childhood cancer survivors.

Frequent co-authors collaborating with Genevieve Laureys include:

  • Ruth Ladenstein
  • Victoria Castel
  • Cormac Owens
  • Gudrun Schleiermacher
  • Bram De Wilde

Genevieve Laureys has published in several scientific venues, with multiple contributions to:

  • Journal of Clinical Oncology
  • European Journal of Pediatrics
  • Cancers
  • Journal of Hepatology
  • Epigenetics

Key recent papers authored or co-authored by Genevieve Laureys include:

  • Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1), 2020, Cancers
  • Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications, 2020, Journal of Hepatology
  • Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study, 2020, Journal of Clinical Oncology
  • Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1), 2021, Journal of Clinical Oncology
  • The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review, 2020, European Journal of Pediatrics

Best Publications

  • Identification of ALK as a major familial neuroblastoma predisposition gene

    Yaël P. Mossé;Marci Laudenslager;Luca Longo;Kristina A. Cole

  • Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

    N Bown;S Cotterill;M Lastowska;S O'Neill

  • Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.

    H.N. Caron;P. van Sluis;J. de Kraker;J.P.M. Bökkerink

  • Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

    Ruth Ladenstein;Ruth Ladenstein;Ulrike Pötschger;Andrew D J Pearson;Penelope Brock

  • Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

    Ruth Ladenstein;Ulrike Pötschger;Dominique Valteau-Couanet;Roberto Luksch

  • Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

    Sara De Brouwer;Katleen De Preter;Candy Kumps;Piotr Zabrocki

  • Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma

    Evemie Schutyser;Sofie Struyf;Paul Proost;Ghislain Opdenakker

  • ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma.

    Pascale De Paepe;Mathijs Baens;Mathijs Baens;Han van Krieken;Han van Krieken;Bruno Verhasselt;Bruno Verhasselt

  • I;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines

    N Van Roy;G Laureys;N C Cheng;P Willem

  • Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

    Joëlle Vermeulen;Katleen De Preter;Arlene Naranjo;Liesbeth Vercruysse

  • Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma

    Jo Vandesompele;Michael Baudis;Katleen De Preter;Nadine Van Roy

  • Quantification of MYCN, DDX1, and NAG Gene Copy Number in Neuroblastoma Using a Real-Time Quantitative PCR Assay

    Katleen De Preter;Frank Speleman;Valérie Combaret;John Lunec

  • Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization

    Jo Vandesompele;Nadine Van Roy;Mireille Van Gele;Geneviève Laureys

  • An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

    P. Mestdagh;Erik Fredlund;Erik Fredlund;F. Pattyn;A. Rihani

  • Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification

    D. Plantaz;J. Vandesompele;N. Van Roy;M. Łastowska

  • Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification

    Huib Caron;Martine Peter;Peter van Sluis;Frank Speleman

  • Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

    Ruth Ladenstein;Domonique Valteau-Couanet;Penelope Brock;Isaac Yaniv

  • The expression and role of CXC chemokines in colorectal cancer.

    Hannelien Verbeke;Sofie Struyf;Geneviève Laureys;Jozef Van Damme

  • MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors

    P Mestdagh;E Fredlund;F Pattyn;J H Schulte

  • Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

    B De Bernardi;V Mosseri;H Rubie;V Castel

Frequent Co-Authors

Franki Speleman
Franki Speleman Ghent University
Jo Vandesompele
Jo Vandesompele Ghent University
Katleen De Preter
Katleen De Preter Ghent University
Nadine Van Roy
Nadine Van Roy Ghent University
Rogier Versteeg
Rogier Versteeg University of Amsterdam
Johannes H. Schulte
Johannes H. Schulte Charité - University Medicine Berlin
Anne De Paepe
Anne De Paepe Ghent University Hospital
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Ghislain Opdenakker
Ghislain Opdenakker Rega Institute for Medical Research
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can lead to diverse careers in healthcare, research, and management. Many students are now considering online degree options for greater flexibility and accessibility. For example, degrees such as an exercise science degree online accredited offer pathways into physical therapy, fitness, and health education.

Those interested in advancing clinical practice skills might consider an msn to dnp online no clinicals program, which enables nurses to reach the highest professional level without the need for traditional, in-person clinical rotations.

If management aligns with your interests, a doctorate in healthcare management can prepare you for leadership roles in hospitals, clinics, or public health organizations. For those drawn to the pharmaceutical sector, there are online pharmd programs for non pharmacists, opening doors to new careers in pharmacy without a prior pharmacy degree.

These options highlight the growing range of online degrees that support a variety of career pathways in the fields relating to Biology and Biochemistry.

Best Scientists Citing Genevieve Laureys

Trending Scientists

Recently Published Articles